share_log

Keybanc Maintains Overweight on Steris, Raises Price Target to $258

Benzinga ·  Aug 3, 2023 04:40

Keybanc analyst Matthew Mishan maintains Steris (NYSE:STE) with a Overweight and raises the price target from $254 to $258.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment